Indicated for: mild restlessness; minor sleep disorders
Route of administration: oral
Substance: dry valerian extract + phenobarbital (plant extract + antiepileptic)
ATC: N05CB02 (Nervous system | Hypnotics and sedatives | Barbiturates, combinations)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
The dose must be followed strictly.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
Use during breastfeeding only on medical advice.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Seek medical help if suicidal thoughts or major behavior changes occur.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
The combination of dry valerian extract and phenobarbital is used for the treatment of sleep disorders, anxiety, and other stress-related conditions. Valerian extract has sedative and anxiolytic properties, while phenobarbital, a barbiturate, enhances sedative effects through its action on GABA receptors in the central nervous system.
This combination is administered orally, usually in tablet form, and the dosage is adjusted based on the severity of symptoms and the patient's response. It is recommended for short-term use to avoid the risk of dependence associated with phenobarbital.
Common side effects include drowsiness, dizziness, fatigue, and, in rare cases, allergic reactions. Additionally, phenobarbital may interact with other medications, increasing the risk of adverse effects.
The combination of valerian extract and phenobarbital provides an effective option for managing sleep disorders and anxiety, but its use should be carefully monitored to minimize associated risks.